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Abstract
Introduction: Transient hypogammaglobulinaemia of infancy (THi) is a primary immunodeficiency 
characterised by low levels of immunoglobulin G (often with concomitant decrease of igA and some-
times also of igM) with still unknown exact reason. A delayed normalisation of the immunoglobulin 
level in THi may be associated with a transiently elevated number of regulatory T cells (Treg). Although 
in cancer and chronic inflammation it was shown that the level of Treg cells can be increased by my-
eloid-derived suppressor cells (mdSCs), until now no studies have been performed in the context of 
the role of MdSCs in THi and their correlation with Treg cells. Consequently, we aimed to determine 
the occurrence of MdSCs in the peripheral blood of children with THi and correlate their level with 
the level of Treg cells.
Material and methods: flow cytometry analyses of mo-mdSCs and gr-mdSCs, characterised as 
Hla-dR–Cd11b+Cd15–Cd14+ and Hla-dR–Cd11b+Cd15+Cd14–, respectively, and Treg (Cd4+C-
d25+Foxp3+) cells were performed.
Results: the proportion of mo-mdSCs and gr-mdSCs was significantly higher in the group of tHI 
patients with elevated level of Treg cells (from the 95% confidence interval level of healthy controls). 
the cells with mo-mdSC and gr-mdSC characteristics positively correlated with the level of treg 
cells. Moreover, children with a higher proportion of circulating Treg cells, and thereby higher level of 
MdSCs, showed delayed normalisation of igG level and recovery.
Conclusions: These findings show for the first time that MdSCs may be involved in the pathomech-
anism of THi, probably acting through the induction of Treg cells.
Key words: MdSCs, regulatory T cells, THi.
(Centr eur J Immunol 2018; 43 (4): 413-420)
Introduction
Myeloid-derived suppressor cells (MDSCs) compose 
a heterogeneous population of immature myeloid pro-
genitors with immunosuppressive properties [1, 2]. It has 
been demonstrated that the level of MDSCs increases in 
chronic inflammatory conditions, infections, and cancer, 
contrary to healthy individuals, where MDSCs represent 
a scant percentage [1, 3]. Several studies have shown that 
human MDSCs are phenotypically characterised as neg-
ative for linear markers CD3 and CD19, low expression 
of HLA-DR, and high expression of CD33 and CD11b. 
In peripheral blood MDSCs are divided into two main 
subpopulations: monocytic (Mo-MDSCs) and granulo-
cytic (Gr-MDSCs), identified as CD11b+CD33+HLA-DR–
CD14+CD15– and CD11b+CD33+HLA-DR–CD14–CD15+, 
respectively, as recommended by the Mye-EUNITER 
consortium [3, 4]. It has been shown that MDSC-medi-
ated immunosuppression involves multiple mechanisms, 
Central European Journal of Immunology 2018; 43(4)
Izabela Siemińska et al.
414
such as inhibition of adaptive immune response mediat-
ed by CD4+ and CD8+ T cells [5, 6] as well as induction 
of the immunosuppressive population of regulatory T 
(Treg) cells [7]. Moreover, crosstalk between Treg cells 
and MDSCs has been clearly documented [7, 8], and the 
main factors released by MDSCs involved in the induc-
tion of Treg cells have been identified as: IL-10, trans-
forming growth factor β (TGF-β), enzymes – arginase-1 
(ARG1) (E.C. 3.5.3.1), and inducible nitric oxide synthase 
(NOS2) (EC 1.14.13.39), which reduce the concentration 
of L-arginine in the tissue milieu [9]. Furthermore, NOS2 
and NADPH oxidase have been shown to be responsible 
for upregulation of reactive nitrogen species (RNS) and 
reactive oxygen species (ROS). These two mechanisms 
cause inhibition of T-cell proliferation by blocking CD3 
zeta chain expression [10, 11]. Gr-MDSCs mainly generate 
ROS, whereas Mo-MDSCs produce higher levels of RNS 
[12]. The longer half time of NO than ROS determines that 
Mo-MDSCs are considered to be more suppressive than 
Gr-MDSCs and do not need direct cell-to-cell contact to 
maintain their suppressive functions [13, 14].
Although MDSCs were initially identified and charac-
terised as a new population that plays an important role in 
cancer progression [15, 16], the list of conditions in which 
MDSCs are relevant is still getting longer. Over the last 
few years an increasing number of reports have described 
their role in viral infections [17], bacterial infections [18], 
parasitic infections [19], traumatic stress [20], and condi-
tions after organ transplantation [21]. However, there are 
no data showing the potential role of MDSCs in the patho-
genesis of any primary immunodeficiency disease (PIDs).
Predominantly, immunoglobulin deficiencies are 
the most common forms of PIDs [22, 23]. One of them, 
transient hypogammaglobulinaemia of infancy (THI), is 
a heterogeneous disorder characterised by reduced serum 
IgG (often IgA and sometimes also IgM) level in early 
childhood and recurrent infections, mostly of the respira-
tory tract [24-26]. A putative diagnosis is initially made 
after exclusion of other causes of hypogammaglobulinae-
mia, while a definitive diagnosis of THI can only be made 
retrospectively in patients with normalised IgG levels and 
withdrawal of clinical symptoms, which occurs usually 
between the second and fourth year of life [27]. The un-
derlying definitive basis of this disorder is still unknown. 
Based on the latest reports, a possible role of a transiently 
elevated number of Treg cells in THI patients was consid-
ered. It was shown that the initially elevated Treg cells in 
patients with THI decreases with age, reaching at the time 
of recovery the levels observed in healthy subjects. De-
crease of Treg cells in the THI group was associated with 
normalisation of immunoglobulin level and withdrawal of 
clinical symptoms [28]. Furthermore, inhibitory effects of 
Treg cells on B-cell functions and immunoglobulin pro-
duction were described [29, 30]. Thus, it was interesting 
to analyse whether the level of MDSCs in peripheral blood 
of THI patients is elevated at the time of initial diagnosis 
and correlates with the proportion of circulating Treg cells. 
Material and methods
Patients
The studied group was selected from patients referred 
to the outpatient clinic of the Department of Clinical Im-
munology, University Children’s Hospital in Krakow, 
Poland. All patients were diagnosed according to criteria 
of the International Union of Immunological Societies 
[31]. Sixteen patients (13 boys and 3 girls), whose levels 
of immunoglobulins normalised with age, were retrospec-
tively classified as THI. Such a gender distribution was 
a consequence of including consecutive patients from the 
outpatient clinic. The mean age of patients at the time of 
initial diagnosis was 9.2 ±7.06 months. Children in whom 
immunodeficiency diseases were excluded (n = 6), formed 
gender (five boys and one girl) and an age-matched control 
group. Written, informed consent was obtained from the 
legal representatives of the patients. The Bioethical Com-
mittee of Jagiellonian University approved the study (no. 
122.6120.195.2015). Determination of the level of MDSCs 
and Treg cells was made at the time of initial diagnosis 
and considered for analysis after retrospective verification.
Isolation of peripheral blood mononuclear cells
Whole peripheral blood samples from patients and 
healthy control subjects were drawn to EDTA-containing 
tubes (Vacutainer System; Becton Dickinson, San Jose, 
CA). Peripheral blood mononuclear cells (PBMC) were 
isolated by the standard Ficoll-Paque (Pharmacia, Uppsala, 
Sweden) density gradient centrifugation.
Determination of Mo-MDSC and Gr-MDSC 
levels
For MDSCs analysis, PBMC (app. 1 × 106 cells) were 
stained with the following monoclonal antibodies (mAbs): 
anti-HLA-DR-PerCP (clone L243), anti-CD11b-BV510 
(clone ICR F44), anti-CD14-FITC (clone MφP9), and 
anti-CD15-PE-Cy7 (clone HI98) (all from Pharmingen, 
BD Biosciences, San Diego, CA) for 20 min in 4°C. Af-
ter incubation, cells were washed twice in PBS and sus-
pended in 0.2 ml PBS. In order to determine the level of 
non-specific staining and autofluorescence, fluorescence 
minus one (FMO) control samples were incubated in par-
allel. The samples were analysed in a FACSCanto flow 
cytometer (BD Biosciences, Immunocytometry systems, 
San Jose, CA) using FACSDiva software (BD Bioscienc-
es). The Mo-MDSCs were characterised as HLA-DR–CD-
11b+CD14+CD15– cells and presented as the percentage 
of nucleated cells (NC) (positive for SYTO™ 9 staining; 
Invitrogen, Eugene, OR), whereas Gr-MDSCs, like HLA-
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DR–CD11b+CD14–CD 15+ cells, were presented also as 
a percentage of NC (Fig. 1).
Determination of Treg cell levels
For Tregs cell analysis, PBMCs were stained using 
a Human Regulatory T-cell Staining Kit (BD Bioscienc-
es) with the following mAbs: anti-CD4-FITC, anti-CD25-
PE, and anti-Foxp3-APC, according to the manufacturer’s 
instructions. In parallel, a control sample was prepared to 
determine the non-specific binding of antibodies (isotype 
control). Samples were analysed in a FACSCanto flow cy-
tometer using FACSDiva software. The level of Treg cells 
was calculated as the proportion of CD4+CD25+Foxp3+ 
cells from the whole CD4+ population.
Assessment of the immunoglobulin level 
Concentrations of serum immunoglobulins IgG and 
IgA were determined by nephelometry method (BNII 
nephelometer; Dade-Behring, Deerfield, IL; antisera from 
Behring) during routine laboratory tests.
Statistical analysis
Statistical analysis was performed using the PRISM 
GraphPad 5 package (GraphPad Software Inc., San Diego, 
CA, USA). Obtained data were analysed using t-test or 
one-way analysis of variance (ANOVA) with Dunnett’s 
Multiple Comparison Test, as a post hoc test. The magni-
tude of the relationship between two quantitative features 
was evaluated using Pearson’s correlation coefficient. Nor-
mality before t- test was tested by Shapiro-Wilk test, and 
for non-parametric data U-Mann-Whitney test was used 
(comparison of Mo-MDSC and Gr-MDSC levels in THI 
and healthy controls). All data are expressed as mean ±SD. 
The level p < 0.05 was considered statistically significant.
Results
Treg cells in THI patients and healthy controls
The patient group was composed of 16 children (mean 
age at the time of initial diagnosis was 9.2 ±7.06 months), 
in whom, retrospectively, THI was diagnosed, according 
to criteria of the International Union of Immunological 
Societies. There was no statistical difference in the Treg 
cell level between THI patients and healthy controls (CTR) 
(1.53% ±0.75% in CTR vs. 3.33% ±2.40% in THI, p = 
0.0919) (Fig. 2A). Because our THI group was highly het-
erogeneous in respect to Treg cell level, it was somewhat 
arbitrarily divided into two subgroups, as we did previ-
ously [28]. The first group, named “THI low”, consist-
ed of seven patients with Treg cell level comparable to 
healthy controls, whereas in the second group, containing 
nine patients and named “THI high”, the Treg cell level 
was from the 95% confidence interval level of the healthy 
control (0.75-2.32% of Foxp3+ from CD4+ cells). We ap-
plied such an arbitrary division of the patients’ group due 
to the small number of patients included and the inabili-
ty to apply another type of analysis, e.g. cluster analysis, 
based on our previous studies [28]. The proportion of Treg 
cells in the “THI high” group was found to be significantly 
higher than in healthy controls (1.53% ±0.75% in CTR vs. 
5.06% ±1.67% in “THI high”, p < 0.05), as well as in the 
“THI low” group (5.06% ±1.67% in “THI high” vs. 1.09% 
±0.56% in “THI low”, p < 0.001) (Fig. 2B).
Mo-MDSCs and Gr-MDSCs levels in THI 
patients and healthy controls
In the next step, the proportions of Mo-MDSCs and 
Gr-MDSCs in peripheral blood of THI patients were ana-
lysed and compared with healthy controls. There was no 
statistical difference between the calculated mean percent-
Fig. 1. Gating strategy for flow cytometry identification of Mo-MDSCs and Gr-MDSCs in the peripheral blood of THI 
patients
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p < 0.05
p < 0.05
age value of Mo-MDSCs in the group of THI patients and 
controls (0.27% ±0.18% in CTR vs. 1.66% ±2.58% in 
THI, p = 0.0676) (Fig. 3A). However, it reached statistical 
significance when referring to the “THI high” group, com-
pared to the controls (0.27% ±0.18% in CTR vs. 2.71% 
±3.09% in “THI high”, p < 0.05) or to the “THI low” 
group of children (2.71% ±3.09% in “THI high” vs. 0.30% 
±0.30% in “THI low”, p < 0.05) (Fig. 3B). In respect to the 
second population of MDSCs, the mean percentage value 
of Gr-MDSCs in peripheral blood was significantly higher 
in THI patients in comparison to the control group (0.58% 
±0.53% in CTR vs. 13.17% ±15.54% in THI, p = 0.0036) 
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(Fig. 3C). Similarly, as was done for Mo-MDSCs, the lev-
el of Gr-MDSCs was calculated also in the two selected 
subgroups of THI patients. Accordingly, the mean percent-
age value of Gr-MDSCs in the “THI high” group was sig-
nificantly elevated, compared to controls (0.58% ±0.53% 
in CTR vs. 17.73% ±19.57% in “THI high”, p < 0.05) 
and THI children with a low level of Treg cells (7.73% 
±19.57% in “THI high” vs. 7.30% ±4.67% in “THI low”, 
p < 0.05 ) (Fig. 3D).
Correlation between the level of Treg cells and 
MDSCs
Next, we asked whether any correlation exists be-
tween the level of Treg cells and MDSCs in the blood of 
THI patients. The obtained results indicated a statistically 
significant positive correlation between the level of Treg 
cells and proportions of cells with Mo-MDSCs as well as 
Gr-MDSCs phenotype (Fig. 4). Correlation with MDSCs 
and Treg cells in THI patients indicates that the “THI low” 
group consists of patients with lower (than controls) levels 
of Treg cells, Mo-MDSCs, and Gr-MDSCs, whereas pa-
tients with higher (than controls) levels of these cell pop-
ulations have been included into the “THI high” group. 
There was no correlation between the cumulative level of 
both MDSC populations and Treg cells in THI patients 
(data not shown).
Time required for IgG normalisation in THI 
groups
Finally, it was interesting to ask whether there were 
differences in the duration required for IgG normalisation, 
in respect to the level of circulating Treg and MDSCs at 
the time of initial diagnosis. This correlation was analysed 
in the “THI low” and “THI high” groups of patients. The 
obtained results indicated that IgG level normalised sig-
nificantly more slowly in the group of children with high 
levels of Treg, Mo-MDSCs, and Gr-MDSCs (“THI high”) 
compared to the group with low Treg, Mo-MDSC, and 
Gr-MDSC proportions (“THI low”) (25.56 ±9.13 months 
in “THI high” vs. 14.57 ±4.24 months in “THI low”, p = 
0.0109) (Fig. 5).
Discussion
The strong regulatory effects of MDSCs have been 
reported in various clinical conditions, including cancer, 
infections, chronic inflammation, autoimmunity, and sta-
tus post organ transplantation [17-21]. Accumulated data 
has already confirmed the immunosuppressive nature of 
MDSCs by documenting their ability to inhibit effector 
T cell [32] or macrophage [33] activity, as well as induc-
tion of Treg cells [34]. However, up to now the associa-
tion of MDSCs with the level of Treg cells has not been 
analysed in PIDs. 
Previously, we reported a possible role of Treg cells 
in the pathomechanism of THI, where elevated levels of 
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Treg cells were associated with hypogammaglobulinaemia 
[28, 29]. Based on this, in the current study, we aimed to 
analyse the level of Mo-MDSC and Gr-MDSC populations 
in the peripheral blood of THI patients and check whether 
it correlates with the level of Treg cells at the time of initial 
diagnosis. 
Our findings demonstrate that in the THI group with 
a higher proportion of Treg cells, the level of MDSCs was 
also significantly higher. Conversely, in THI patients with 
a low proportion of circulating Treg cells, the level of 
Mo-MDSCs was comparable to healthy control subjects, 
whereas the level of Gr-MDSCs was higher. These obser-
vations suggest that MDSCs in THI patients may induce 
Treg cells that directly inhibit IgG production by B lym-
phocytes [35]. A positive correlation between MDSCs and 
Treg cells was previously described mainly in cancer pa-
tients [36, 37], where MDSCs could induce Treg cells by 
IL-10 and TGF-β production [37]. From the other hand, 
Treg cells can enhance MDSCs function and control their 
differentiation through a mechanism involving TGF-β, be-
cause TGF-β-deficient Treg cells were not able to regulate 
MDSCs function in an experimentally induced model of 
colitis [38]. This indicates a positive feedback loop estab-
lished between these two cell types [38]. It is worth point-
ing out that in our study the proportion of Gr-MDSCs bet-
ter correlated with Treg cells than the level of Mo-MDSCs 
did, which could suggest that the Gr-MDSCs population is 
mainly involved in inhibition of immunoglobulin produc-
tion, confirming their suppressive role on B lymphocytes 
[39].
The mechanism underlying MDSC activation in THI 
patients remains unclear. Nevertheless, we assume that the 
factors similar to those seen in cancer patients could be 
involved in this process [40], especially that the elevated 
levels of tumour necrosis factor α (TNF-α) and IL-10 have 
been shown previously in the serum of THI patients [41].
Additionally, analysis of the relationship between the 
age of the patients and their IgG level has shown a positive 
correlation up to the normalisation of IgG, as confirmed 
by the previous studies [28]. Therefore, we checked if the 
level of Treg cells has any impact on the duration required 
for IgG normalisation in THI patients. For this purpose, 
we compared the age of patients with normalised IgG 
level from the group to those with a low and high Treg 
cell level: “THI high” and “THI low”, respectively. We 
noticed that in the group with a high level of Treg cells, 
and thereby also MDSCs, the patients did normalise their 
IgG level at the mean age of 26 months, while in the group 
with a low proportion of Treg, all patients aligned the IgG 
concentrations to the normal range almost one year earlier 
on average (Fig. 5). 
In THI patients with a low number of Treg cells, the 
level of MDSCs was also lower and comparable to control 
subjects. Our previous study in the group of children with 
THI showed that up-regulation of IL-12 secretion was as-
sociated with hypogammaglobulinaemia. Moreover, during 
normalisation of IgG level, a decrease of IL-12 level was 
also observed in these patients [42]. In this context, we 
hypothesise that IL-12 could play a role in the reduction 
of MDSCs level in THI patients during their recovery. Al-
though we do not have formal proof, we suggest the likely 
pathomechanism of THI, based on the positive correla-
tion between the levels of MDSCs and Treg cells (Fig. 6). 
This hypothesis, however, needs to be further verified with 
functional assays.
We are aware that the group of patients in our study 
was small, but because THI is a disease with rather rare 
frequency, it would be difficult to collect a sufficiently 
large group of patients in a reasonable timeframe. More-
over, due to ethical reasons, our study has obvious limita-
tions and should be regarded with caution; however, the 
presented positive correlation between the level of Treg 
Fig. 6. Simplified scheme of the proposed interactions between MDSCs, Treg cells, and B lymphocytes in THI
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cells and MDSCs suggests a crucial role played by these 
cells in THI.
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